跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,077 条关于
“IEC-HS”
全部
9,077
临床试验
1,697
药物
1,396
机构
5,415
资讯
569
去年
Ruxolitinib Shows Promise in Treating CAR T-Cell Therapy-Induced Parkinsonism in Multiple Myeloma
前天
Novartis and BMS pause autoimmune CAR T trials over safety concerns
去年
CARGO Therapeutics Discontinues Phase 2 Firi-Cel Trial in R/R LBCL Due to Safety, Durability Concerns
17天前
Novartis, Bristol Myers pause autoimmune CAR-T trials after inflammatory safety signals
去年
Cargo Therapeutics Halts CAR-T Development After Safety Concerns, Announces 50% Staff Reduction
去年
ALLO-316 CAR-T Therapy Shows Promise in Renal Cell Carcinoma Trial, but Deaths Reported
去年
FDA Approves Bimzelx (bimekizumab-bkzx) for Moderate-to-Severe Hidradenitis Suppurativa
去年
Secukinumab Demonstrates Improvement in Hidradenitis Suppurativa Symptoms and Psychiatric Comorbidities
2年前
HS-20093 Shows Promise in Pretreated Extensive-Stage Small Cell Lung Cancer
去年
Bimekizumab Shows Promise in Long-Term Management of Hidradenitis Suppurativa
第 1 页,共 57 页
上一页
下一页